Form4insider filings, from the source

SEC Form 4 · accession 0000899243-15-003075

Baxalta Inc · BXLT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jacopo Leonardi
Officer — EVP and President, Immunology
Period of report
Aug 11, 2015
Accepted (ET)
Aug 13, 2015 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001620546

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.01 per shareAug 11, 2015A44$0.00A27,921D
Common Stock, par value $0.01 per shareAug 11, 2015A56$0.00A27,977D
Common Stock, par value $0.01 per shareholding———1,091IBy 401(k) Plan

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses